- Home
- ANL vs RBOT Comparison
ANL vs RBOT Comparison
Compare ANL & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANL | RBOT |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 17.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANL | RBOT |
|---|---|---|
| Price | $1.01 | $2.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 13.6K | ★ 153.3K |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.44 |
| 52 Week High | $2.99 | $18.97 |
Technical Indicators
Market Signals| Indicator | ANL | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 39.85 |
| Support Level | $1.32 | $2.54 |
| Resistance Level | $1.59 | $3.66 |
| Average True Range (ATR) | 0.15 | 0.38 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 1.69 | 44.26 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.